93 related articles for article (PubMed ID: 7857106)
1. [Delayed clearance of methotrexate in a patient with malignant lymphoma who developed renal failure].
Wakita A; Komatsu H; Banno S; Nitta M; Nagai H; Uchida T; Murase T; Nakahara Y; Tanaka M
Gan To Kagaku Ryoho; 1995 Feb; 22(2):285-8. PubMed ID: 7857106
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis.
Ahmad S; Shen FH; Bleyer WA
Arch Intern Med; 1978 Jul; 138(7):1146-7. PubMed ID: 666479
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
[TBL] [Abstract][Full Text] [Related]
4. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
[TBL] [Abstract][Full Text] [Related]
5. Acute renal failure after high-dose methotrexate therapy in a patient with ileostomy.
ASADA D; MATSUBARA H; KATO I; OSADA K; URYU K; TOKUMASU M; UMEDA K; WATANABE K; ADACHI S; OKAMOTO S; UEMOTO S; NAKAHATA T
Rinsho Ketsueki; 2009 Nov; 50(11):1607-11. PubMed ID: 20009434
[TBL] [Abstract][Full Text] [Related]
6. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
[TBL] [Abstract][Full Text] [Related]
7. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
Weigel R; Senn P; Weis J; Krauss JK
Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
Park J; Franco RS; Augsburger JJ; Banerjee RK
Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
10. Prolonged accumulation of high-dose methotrexate in a case with large liver cysts.
Kawakami M; Omori H; Yamagami T; Soma T
Cancer Chemother Pharmacol; 2009 Aug; 64(3):619-22. PubMed ID: 19319534
[TBL] [Abstract][Full Text] [Related]
11. [Management recommendations in patients with methotrexate intoxication].
Schellens JH; Beijnen JH
Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
[TBL] [Abstract][Full Text] [Related]
13. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
14. Late-onset delayed excretion of methotrexate.
Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
[TBL] [Abstract][Full Text] [Related]
15. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
[TBL] [Abstract][Full Text] [Related]
16. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
[TBL] [Abstract][Full Text] [Related]
17. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
[TBL] [Abstract][Full Text] [Related]
18. [Managing methotrexate toxicity: a case report].
Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
[TBL] [Abstract][Full Text] [Related]
19. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
Skärby T; Jönsson P; Hjorth L; Behrentz M; Björk O; Forestier E; Jarfelt M; Lönnerholm G; Höglund P
Cancer Chemother Pharmacol; 2003 Apr; 51(4):311-20. PubMed ID: 12721759
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]